Imbria Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Imbria Pharmaceuticals's estimated annual revenue is currently $2.5M per year.
- Imbria Pharmaceuticals's estimated revenue per employee is $155,000
Employee Data
- Imbria Pharmaceuticals has 16 Employees.
- Imbria Pharmaceuticals grew their employee count by -6% last year.
Imbria Pharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | Director, Clinical Operations | Reveal Email/Phone |
2 | President and CEO | Reveal Email/Phone |
Imbria Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Imbria Pharmaceuticals?
Imbria Pharmaceuticals' mission is to translate our understanding of cellular metabolism into innovative medicines that improve the lives of patients with limited or inadequate treatment options. The company was founded by doctors and launched by an all doctor executive team motivated by the promise of bringing new therapies to people in need. We are propelled by a deep scientific interest in cellular metabolism and the mitochondria, and are guided by both values and a code of business conduct built upon our commitment to always put the patients, families and communities we serve at the forefront of all that we do.
keywords:N/AN/A
Total Funding
16
Number of Employees
$2.5M
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Imbria Pharmaceuticals News
BOSTON--(BUSINESS WIRE)--Imbria Pharmaceuticals, Inc., a clinical stage, cardio-metabolic company developing novel therapies designed to...
Imbria is a privately held, clinical stage, cardio-metabolic company focused on improving energy production in the mitochondria and balancing...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.4M | 16 | -20% | N/A |
#2 | $1.4M | 16 | N/A | N/A |
#3 | $0.5M | 16 | -11% | $3.7M |
#4 | $0.5M | 16 | 0% | $8.8M |
#5 | $2.3M | 16 | N/A | N/A |